IL33 and neoplasm: Although sST2-Fc seems to be weaker in suppressing the malignant growth of CRC cells than tumour cell-derived native sST2, it may be due to its lower affinity to IL-33 or a shortage of local accumulation of the protein in the tumour tissues.